Location History:
- Keasbey, NJ (US) (2015)
- Littleton, MA (US) (2023)
Company Filing History:
Years Active: 2015-2023
Title: The Innovations of Manoj K Sharma
Introduction
Manoj K Sharma is a notable inventor based in Keasbey, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of stable formulations of antibodies for cancer treatment. With a total of 2 patents, his work has the potential to impact the medical community significantly.
Latest Patents
Manoj K Sharma's latest patents include innovative formulations of programmed death receptor 1 (PD-1) antibodies. The first patent focuses on stable formulations of these antibodies, which are crucial for treating various cancers. The invention details formulations that comprise between 5-200 mg/mL of anti-PD-1 antibody or its antigen-binding fragments. The methods described in this patent allow for intravenous or subcutaneous administration to patients. The second patent also addresses stable formulations of antibodies against human PD-1, providing methods for treating chronic infections alongside cancers.
Career Highlights
Manoj K Sharma is currently associated with Merck Sharp & Dohme Corporation, a leading pharmaceutical company. His work at Merck has allowed him to focus on groundbreaking research in antibody formulations, contributing to advancements in cancer therapies.
Collaborations
Some of his notable coworkers include Chakravarthy Nachu Narasimhan and Kevin James Gergich. Their collaborative efforts in research and development have further enhanced the impact of their work in the field.
Conclusion
Manoj K Sharma's contributions to the field of biotechnology through his patents on PD-1 antibodies exemplify the innovative spirit of modern inventors. His work not only advances scientific knowledge but also holds promise for improving cancer treatment options.